Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1967 5
1968 5
1969 6
1970 6
1971 6
1972 4
1973 17
1974 22
1975 54
1976 29
1977 17
1978 15
1979 16
1980 19
1981 15
1982 22
1983 38
1984 36
1985 36
1986 37
1987 49
1988 51
1989 58
1990 63
1991 63
1992 78
1993 110
1994 109
1995 91
1996 89
1997 85
1998 121
1999 96
2000 95
2001 70
2002 67
2003 87
2004 94
2005 99
2006 120
2007 104
2008 84
2009 68
2010 82
2011 89
2012 81
2013 72
2014 79
2015 94
2016 80
2017 70
2018 68
2019 57
2020 49
2021 68
2022 27
Text availability
Article attribute
Article type
Publication date

Search Results

3,057 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Steinberg KP, et al. N Engl J Med. 2006 Apr 20;354(16):1671-84. doi: 10.1056/NEJMoa051693. N Engl J Med. 2006. PMID: 16625008 Free article. Clinical Trial.
CONCLUSIONS: These results do not support the routine use of methylprednisolone for persistent ARDS despite the improvement in cardiopulmonary physiology. In addition, starting methylprednisolone therapy more than two weeks after the onset of ARDS may increase the r …
CONCLUSIONS: These results do not support the routine use of methylprednisolone for persistent ARDS despite the improvement in cardio …
A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.
Beck RW, Cleary PA, Anderson MM Jr, Keltner JL, Shults WT, Kaufman DI, Buckley EG, Corbett JJ, Kupersmith MJ, Miller NR, et al. Beck RW, et al. N Engl J Med. 1992 Feb 27;326(9):581-8. doi: 10.1056/NEJM199202273260901. N Engl J Med. 1992. PMID: 1734247 Free article. Clinical Trial.
RESULTS: Visual function recovered faster in the group receiving intravenous methylprednisolone than in the placebo group; this was particularly true for the reversal of visual-field defects (P = 0.0001). ...CONCLUSIONS: Intravenous methylprednisolone followed by or …
RESULTS: Visual function recovered faster in the group receiving intravenous methylprednisolone than in the placebo group; this was p …
Comparison of the Efficacy of Dexamethasone and Methylprednisolone in Infiltration Injection for Postendodontic Pain in Patients with Necrotic Pulp: A Randomized Controlled Clinical Trial.
Yeganegi S, Fazelian N, Layegh Nejad MK, Manzouri L. Yeganegi S, et al. Pain Res Manag. 2022 Feb 23;2022:4163120. doi: 10.1155/2022/4163120. eCollection 2022. Pain Res Manag. 2022. PMID: 35251416 Free PMC article. Clinical Trial.
This clinical study aimed to evaluate the effect of infiltration injection of dexamethasone and methylprednisolone on postendodontic pain in patients with necrotic pulp. ...CONCLUSIONS: Infiltration injection of dexamethasone and methylprednisolone had a significant …
This clinical study aimed to evaluate the effect of infiltration injection of dexamethasone and methylprednisolone on postendodontic …
Prophylactic methylprednisolone to reduce inflammation and improve outcomes from one lung ventilation in children: a randomized clinical trial.
Theroux MC, Fisher AO, Rodriguez ME, Brislin RP, Reichard KW, Shah SA, McCoy M, Brown M, Dabney KW, Mackenzie WG, Katz DA, Shaffer TH. Theroux MC, et al. Paediatr Anaesth. 2015 Jun;25(6):587-94. doi: 10.1111/pan.12601. Epub 2015 Jan 2. Paediatr Anaesth. 2015. PMID: 25557228 Free PMC article. Clinical Trial.
Respiratory resistance was lower (P = 0.04) in the methylprednisolone group. Pro-inflammatory cytokine IL-6 was lower (P = 0.01), and anti-inflammatory cytokine IL-10 was higher (P = 0.001) in the methylprednisolone group. ...There were no side effects observed that …
Respiratory resistance was lower (P = 0.04) in the methylprednisolone group. Pro-inflammatory cytokine IL-6 was lower (P = 0.01), and …
Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis.
Ferrante P, Ramsey A, Bunce C, Lightman S. Ferrante P, et al. Clin Exp Ophthalmol. 2004 Dec;32(6):563-8. doi: 10.1111/j.1442-9071.2004.00902.x. Clin Exp Ophthalmol. 2004. PMID: 15575824 Clinical Trial.
Sixty-four eyes from 60 consecutive patients with non-infectious posterior uveitis requiring treatment were allocated on an alternate 1:1 basis to receive either orbital floor methylprednisolone or sub-Tenon triamcinolone using standard procedures and assessed at 6 and 12 …
Sixty-four eyes from 60 consecutive patients with non-infectious posterior uveitis requiring treatment were allocated on an alternate 1:1 ba …
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Ramo-Tello C, Grau-López L, Tintoré M, Rovira A, Ramió i Torrenta L, Brieva L, Cano A, Carmona O, Saiz A, Torres F, Giner P, Nos C, Massuet A, Montalbán X, Martínez-Cáceres E, Costa J. Ramo-Tello C, et al. Mult Scler. 2014 May;20(6):717-25. doi: 10.1177/1352458513508835. Epub 2013 Oct 21. Mult Scler. 2014. PMID: 24144876 Clinical Trial.
OBJECTIVE: The objective of this paper is to compare the clinical and radiologic efficacy, tolerability and safety of intravenous methylprednisolone (ivMP) vs oral methylprednisolone (oMP), at equivalent high doses, for MS relapse. ...
OBJECTIVE: The objective of this paper is to compare the clinical and radiologic efficacy, tolerability and safety of intravenous methylp
Urinary profile of methylprednisolone and its metabolites after oral and topical administrations.
Matabosch X, Pozo OJ, Monfort N, Pérez-Mañá C, Farré M, Marcos J, Segura J, Ventura R. Matabosch X, et al. J Steroid Biochem Mol Biol. 2013 Nov;138:214-21. doi: 10.1016/j.jsbmb.2013.05.019. Epub 2013 Jun 20. J Steroid Biochem Mol Biol. 2013. PMID: 23792784 Clinical Trial.
Methylprednisolone (MP) is prohibited in sports competitions when administered by systemic routes; however its use by topical administration is allowed. ...
Methylprednisolone (MP) is prohibited in sports competitions when administered by systemic routes; however its use by topical adminis
High-dose methylprednisolone in video-assisted thoracoscopic surgery lobectomy: a randomized controlled trial.
Bjerregaard LS, Jensen PF, Bigler DR, Petersen RH, Møller-Sørensen H, Gefke K, Hansen HJ, Kehlet H. Bjerregaard LS, et al. Eur J Cardiothorac Surg. 2018 Jan 1;53(1):209-215. doi: 10.1093/ejcts/ezx248. Eur J Cardiothorac Surg. 2018. PMID: 28977390 Clinical Trial.
RESULTS: Ninety-six patients were included in the primary analysis. Methylprednisolone significantly decreased median pain scores on the day of surgery: at rest (numeric rating scale 1.6 vs 2.0, P = 0.019) and after mobilization to a sitting position (numeric rating scale …
RESULTS: Ninety-six patients were included in the primary analysis. Methylprednisolone significantly decreased median pain scores on …
Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study.
Oliveri RL, Valentino P, Russo C, Sibilia G, Aguglia U, Bono F, Fera F, Gambardella A, Zappia M, Pardatscher K, Quattrone A. Oliveri RL, et al. Neurology. 1998 Jun;50(6):1833-6. doi: 10.1212/wnl.50.6.1833. Neurology. 1998. PMID: 9633736 Clinical Trial.
OBJECTIVE: To assess the efficacy of two different high doses of intravenous methylprednisolone (IVMP) for the treatment of relapses in MS. BACKGROUND: IVMP is the treatment of choice for MS relapses, but it is unknown whether its effects are dose related. ...
OBJECTIVE: To assess the efficacy of two different high doses of intravenous methylprednisolone (IVMP) for the treatment of relapses …
3,057 results